Previous Article | Next Article 
Infection and Immunity, June 2001, p. 3576-3580, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3576-3580.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Conservation of Outer Membrane Protein E among
Strains of Moraxella catarrhalis
Timothy F.
Murphy,*
Aimee L.
Brauer,
Norine
Yuskiw,
Erin R.
McNamara, and
Charmaine
Kirkham
Division of Infectious Diseases, Department
of Medicine, and Department of Microbiology, State University of New
York at Buffalo, and Veterans Affairs Western New York Healthcare
System, Buffalo, New York 14215
Received 30 October 2000/Returned for modification 18 December
2000/Accepted 25 January 2001
 |
ABSTRACT |
Outer membrane protein E (OMP E) is a 50-kDa protein of
Moraxella catarrhalis which has several features that
suggest that the protein may be an effective vaccine antigen. To assess
the conservation of OMP E among strains of M. catarrhalis,
22 isolates were studied with eight monoclonal antibodies which
recognize epitopes on different regions of the protein. Eighteen of 22 strains were reactive with all eight antibodies. The sequences of
ompE from 16 strains of M. catarrhalis were
determined, including the 4 strains which were nonreactive with
selected monoclonal antibodies. Analysis of sequences indicate a high
degree of conservation among strains, with sequence differences
clustered in limited regions of the gene. To assess the stability of
ompE during colonization of the human respiratory tract,
the sequences of ompE of isolates collected from patients
colonized with the same strain for 3 to 9 months were determined. The
sequences remained unchanged. These results indicate that OMP E is
highly conserved among strains of M. catarrhalis, and
preliminary studies indicate that the gene which encodes OMP E remains
stable during colonization of the human respiratory tract.
 |
INTRODUCTION |
Moraxella catarrhalis is
a common and important human respiratory tract pathogen. It is the
third most common cause of otitis media in children, accounting for
approximately 3.5 million episodes of otitis media annually in the
United States (6, 11, 15, 20, 25). Adults with chronic
obstructive pulmonary disease (COPD) experience recurrent lower
respiratory tract infections, often called exacerbations. M. catarrhalis is a common cause of these infections (15, 18,
23, 27, 30). Exacerbations of COPD lead to substantial morbidity
and mortality and increased health care costs worldwide (14, 19,
22). In view of the impact of M. catarrhalis
infections, there is considerable interest in developing a vaccine to
prevent infections caused by M. catarrhalis. Infants would
be immunized to prevent otitis media, with particular emphasis on
preventing otitis media in otitis-prone children who experience
recurrent episodes of otitis media. The second population which would
benefit from such a vaccine would be adults with COPD.
Outer membrane protein E (OMP E) is a 50-kDa heat-modifiable OMP which
has characteristics indicating that it may be an effective vaccine
antigen (3, 4). The protein is expressed in all strains of
M. catarrhalis studied thus far (2, 4, 16). Three independent lines of experiments indicate that OMP E contains epitopes on the bacterial surface; these include adsorption studies with polyclonal antisera raised to whole bacterial cells
(16), immunofluorescence microscopy with polyclonal
antisera raised to purified OMP E (4), and flow cytometry
with monoclonal antibodies (MAbs) (4, 17).
An important consideration in evaluating an OMP as a potential vaccine
is the extent to which the protein is conserved among strains of the
species. An ideal vaccine candidate would be highly conserved among
strains so that immunization with the protein from one strain would
generate protective antibodies to all or most strains of the species.
Studies of OMP E with four MAbs and analysis of PCR restriction
fragment length polymorphisms of ompE suggest that the
protein and gene show conservation among strains (3, 4).
The goal of the present study was to more rigorously assess the degree
of conservation of OMP E by analysis of strains with eight MAbs and to
determine the sequences of ompE of 16 selected strains. In
addition, the stability of ompE in isolates which colonize
the human respiratory tract was assessed preliminarily.
(This work was presented in part at the 101st General Meeting of the
American Society for Microbiology, 20 to 24 May 2001, Orlando, Fla.)
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
Twenty-one clinical
isolates of M. catarrhalis were recovered from sputum
(15), middle ear fluid (2), the nasopharynx (2), the adenoid (1), and sinus aspirate
(1). The geographic sources of the isolates were Buffalo,
N.Y. (15), Birmingham, United Kingdom (2),
Houston, Tex. (1), Philadelphia, Pa. (1),
Mountain Home, Tenn. (1), and Utrecht, The Netherlands (1). Ten of the sputum isolates were recovered from the
sputum of adults monitored in a prospective COPD study clinic (see
below). M. catarrhalis strain ATCC 25240 was obtained from
the American Type Culture Collection. Strains were grown on brain heart
infusion agar at 35°C under 5% CO2.
COPD Study Clinic.
Isolates of M. catarrhalis
were recovered from adults enrolled in a prospective study of COPD at
the Buffalo Veterans Affairs Medical Center. To be included in the COPD
Study Clinic, a patient must have chronic bronchitis as defined by the
American Thoracic Society (1) and be willing to visit the
clinic monthly and at the time of a suspected exacerbation. At each
clinic visit, the patient undergoes a clinical evaluation and serum and
sputum samples are collected. For this study, an equal volume of 6.5 mM
dithiothreitol in phosphate-buffered saline was added to the sputum.
The sputum was mixed by vortexing and incubated at 37°C for 20 min.
After an aliquot of sputum was removed for culture, the mixture was
centrifuged at 27,000 × g for 30 min at 4°C. The sputum supernatants were stored at
80°C. M. catarrhalis
was identified using standard methods, and isolates were stored at
80°C in Mueller-Hinton broth containing 10% glycerol.
Cell envelope preparation.
Bacterial strains were grown
overnight on brain heart infusion plates. Bacteria from one plate were
harvested by suspension in 2 ml of 0.01 M HEPES, pH 7.4. Cells were
pelleted by centrifugation at 1,000 × g for 15 min at
4°C. The pellet was resuspended in 0.5 ml of HEPES buffer and
sonicated three times for 10 s with a Branson Sonifier (small tip,
setting 4). After transfer of the entire suspension to a fresh tube,
cell envelopes were pelleted by centrifugation at 16,000 × g for 45 min at 4°C. The cell envelopes were suspended in ~0.5
ml of HEPES buffer and stored at
20°C until use.
MAbs.
Seven MAbs which recognize epitopes on OMP E have been
described previously (4, 17). MAb 2E11 was developed from
a fusion in which mice were immunized subcutaneously with 50 µg of
purified recombinant OMP E from M. catarrhalis strain ATCC
25240 (4) with incomplete Freund's adjuvant on days 0 and
14. On day 28 the mice received approximately 108 CFU of
M. catarrhalis strain ATCC 25240 intraperitoneally without adjuvant. On day 31, splenocytes were fused with SP2/0-Ag-14
plasmacytoma cells by a modification of the procedure of Kennett
(10) and another previously described method
(21).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
immunoblot assay.
Whole-bacterial-cell lysates and cell envelope
preparations were subjected to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and immunoblot assay as previously described
(17).
ELISA.
Levels of immunoglobulin to OMP E were assayed in
human serum and sputum supernatants by enzyme-linked immunosorbent
assay (ELISA) as previously described (4).
PFGE.
Strains of M. catarrhalis recovered from
the sputum of adults monitored in the COPD Study Clinic were subjected
to pulsed-field gel electrophoresis (PFGE) as previously described
(12). Isolates were determined to be identical to one
another when identical PFGE patterns were observed following the
restriction of genomic DNA separately with both SpeI and
NheI in the pairs of isolates.
Determination of sequences of ompE.
Primers
GCGCGCGGATCCGCAGGCCTGGATCGCTC and
ATATATGAATTCTTTGGCGTGATAAGCAAG were used to amplify
ompE by PCR from genomic DNA prepared using a genomic DNA
kit (Promega). The PCR mixture consisted of 10 ng of genomic DNA, 100 ng of each primer, 1 µl of 10 mM deoxynucleoside triphospate, 5 µl
of Thermopol buffer (New England Biolabs), 0.5 µl of VentI
polymerase (New England Biolabs), and 40.5 µl of water (total volume,
50 µl). After an initial denaturation for 3 min at 94°C, 30 cycles
of the following program were carried out: 94°C for 30 s, 55°C
for 30 s, and 72°C for 1 min. This was followed by incubation at
72°C for 3 min.
The 1,300-bp amplicon was either sequenced directly or cloned into pCR
Blunt (Invitrogen) using the manufacturer's directions. For cloning
into the plasmid, three separate PCRs were performed and the amplicons
were cloned individually into pCR Blunt. The sequences were determined
for two of the clones. If these two sequences differed, then the third
clone would have been subjected to sequencing. For all isolates, the
sequences of the first two clones were identical to one another.
 |
RESULTS |
Strain specificity of MAs.
The 22 isolates (21 clinical
isolates and 1 American Type Culture Collection strain) of M. catarrhalis were assayed with each of the eight MAbs in an
immunoblot assay using either whole-bacterial-cell lysates or cell
envelope preparations. Figure 1 shows the
results of an immunoblot assay with MAb 1B3 for nine clinical isolates of M. catarrhalis. Eight of the clinical isolates were
reactive with MAb 1B3, whereas strain 534 (lane b) was nonreactive. The eight MAbs recognize at least six different epitopes based on the
results of the present study in combination with assays of overlapping
recombinant fusion peptides containing sequences which span OMP E as
reported previously (17). Table
1 shows the regions of OMP E which
contain the epitopes recognized by each of the MAbs. MAb 2E11 was
reactive with full-length OMP E in native form (whole-cell lysates of
M. catarrhalis) and in recombinant form (purified OMP E with
an amino-terminal histidine tag) (4), but it was
nonreactive with each of five overlapping recombinant fusion peptides
which span the sequence of the protein. Therefore, MAb 2E11 recognizes
a conformational epitope on OMP E.

View larger version (84K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblot assay with MAb 1B3. Lanes contain
whole-bacterial-cell lysates of strains 93P3B1 (a), 534 (b), 55P26B1
(c), 47P31B1 (d), 19P7B1 (e), 14P15B1 (f), 12P6B1 (g), 10P28B1 (h), and
3P3B1 (i). Molecular mass standards are noted in kilodaltons on the
right.
|
|
Three of the MAbs (4C11, 9E3, and 2E11) recognized epitopes on all 22 strains (Table
1). Eighteen of the 22 isolates expressed
the epitopes
recognized by MAbs 1B3, 9G10d, 5B3, and 14E10. Of
the four nonreactive
isolates, two were sputum isolates from Buffalo,
N.Y., one was a sputum
isolate from Birmingham, United Kingdom,
and one was a nasopharyngeal
isolate from Utrecht, The Netherlands.
MAb 12D5, which recognizes an
epitope in the region of amino acids
160 to 260, was reactive with 21 of 22 isolates. The nonreactive
isolate was the same sputum isolate
from Birmingham, which was
nonreactive with four other
MAbs.
Sequence analysis of ompE.
The nucleotide sequence
of the gene which encodes OMP E was determined for 16 strains of
M. catarrhalis, including the four isolates which were
nonreactive with some of the eight MAbs. Table 2 shows that OMP E displays a substantial
degree of sequence conservation among strains of M. catarrhalis. Analysis of the amino acid sequences reveals that six
different sequences of OMP E are represented by the 16 strains. Seven
strains which are reactive with all eight MAbs have an identical amino
acid sequence (Table 2, top row). Single amino acid differences among
strains were identified at five positions, as noted in Table 2. In
three additional positions in the protein, differences in two to six
amino acids were noted. These include positions 77 and 78 (VQ versus
IK), positions 112 to 117 (LAYKS versus FTYRRA) and positions 137 and 138 (IV versus TL). Overall, nucleotide sequences were 95.7 to 100%
homologous with ompE of strain ATCC 25240. Amino acid
sequences were 96.6 to 100% identical to OMP E of strain ATCC 25240.
Preliminary epitope analysis.
Since the regions of OMP E
containing epitopes recognized by MAbs are known, correlating patterns
of the reactivity of MAbs with amino acid sequences allows predictions
regarding the location of epitopes recognized by the MAbs. MAbs 1B3 and
9G10d recognize the same, or a closely related, epitope on the
bacterial surface in the region represented by amino acids 80 to 180 (4, 17). Amino acid sequences of OMP E of strains which
were reactive with MAbs 1B3 and 9G10d were compared with sequences of
nonreactive strains. Comparison of sequences in the region of amino
acids 80 to 180 reveals that amino acid 95 (I), amino acids 112 to 116 (LAYKS), and/or amino acids 137 and 138 (IV) are important for reactivity of MAbs 1B3 and 9G10d (Table 2). In an effort to determine whether the MAbs recognize a linear epitope in the region of amino acids 112 to 116 and/or amino acids 137 and 138, individual recombinant fusion peptides representing amino acid sequences 107 to 121, 102 to
126, 130 to 145, and 107 to 145 were expressed and assayed by
immunoblotting. MAbs 1B3 and 9G10d were nonreactive with these fusion
peptides but reactive with the fusion peptide corresponding to amino
acids 80 to 180 as reported previously (data not shown) (17).
MAbs 5B3 and 14E10 recognized an epitope in the nonreduced form of OMP
E in the region of amino acids 240 to 340 (
17). All
11 sequenced strains which were reactive with MAbs 5B3 and 14E10
had an
alanine at position 269, while all 5 sequenced strains
which were
nonreactive has a valine at position 269 (Table
2).
The amino acid
sequence in this region of OMP E was otherwise
identical among all
strains. This observation indicates that the
alanine at position 269 is
important for the reactivity of MAbs
5B3 and
14E10.
Strain 534 is the only strain which is nonreactive with MAb 12D5, which
recognizes an epitope in the region of amino acids
160 to 260 (
17). Strain 534 is also the only one of the 16 sequenced
strains which shows a difference in this region of the protein
(Table
2). Therefore, the lysine at position 202 is critical
for the
reactivity of MAb
12D5.
Stability of ompE in the human respiratory tract.
Three pairs of isolates recovered from the sputum of adults with COPD
who were colonized by M. catarrhalis for durations of 3, 4, and 9 months were studied. PFGE on the prospectively collected isolates
established that the patients were colonized by the same strain during
these periods (Fig. 2). The gene which
encodes OMP E was amplified by PCR and the sequences were determined.
The sequences of ompE from all three sets of isolates were
identical in every nucleotide from the beginning and end of the
colonizing periods. This result indicates that the sequence of
ompE was stable during colonization of the human respiratory
tract in these three pairs of isolates.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
Ethidium bromide-stained pulsed-field gel of genomic DNA
cut with SpeI. The brackets at the top show the pairs of
isolates and patient identification numbers from the COPD Study Clinic.
Lanes contain DNA from strains 5P7B1 (a), 5P10B1 (b), 13P3B1 (c),
13P7B1 (d), 14P15B1 (e), and 14P23B1 (f). Molecular size standards are
noted on the left in kilobases.
|
|
Human antibody response to OMP E.
To determine the extent to
which OMP E was subjected to immune selective pressure while colonizing
the human respiratory tracts of the three patients who were
persistently colonized for 3 to 9 months, antibodies to OMP E were
measured in supernatants of serum and sputum from these patients. Table
3 shows the results of quantitative
ELISAs of serum immunoglobulin G (IgG) and sputum supernatant IgA at
the beginning of the period of colonization. All three patients had
detectable levels of serum IgG, and one of the three patients had
detectable IgA in sputum supernatant. Assays of serum and sputum
supernatants from before and after the colonization revealed that the
level of antibody did not change during the period of colonization by
M. catarrhalis.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Levels of immunoglobulin to OMP E in supernatants of
serum and sputum from three adults with chronic bronchitis colonized by
M. catarrhalis
|
|
 |
DISCUSSION |
Previous work on OMP E suggested that the protein is conserved
among strains of M. catarrhalis. This preliminary conclusion was based on several observations. (i) Adsorption assays with rabbit
polyclonal antiserum showed that OMP E contains surface-exposed determinants that are shared among 17 of 20 strains (16).
(ii) Analysis of PCR restriction fragment length polymorphisms with two
restriction enzymes revealed identical patterns in 20 strains (3). (iii) Four MAbs recognized epitopes in all of the 19 strains studied (4). The present study was undertaken to
rigorously assess the degree of sequence conservation of OMP E among
strains of M. catarrhalis. Analysis of sequences of
ompE from 16 strains revealed that the gene is well
conserved among strains, showing 95.7 to 100% homology in nucleotide
sequence. The protein sequences show 96.6 to 100% identity in
comparison to the previously sequenced gene in strain ATCC 25240 (GenBank accession number L31788).
The sequences of OMP E appear to fall into two clusters based on
sequence differences at positions 95, 112 to 117, 137 and 138, and 269 (Table 2). Analysis of the genetic relationship among strains of
M. catarrhalis has recently been undertaken by several
groups with various methods (5, 13, 26, 28, 29). In
general, a high degree of genetic diversity exists among strains. Of
interest, two studies have observed that complement-resistant strains
form a distinct subpopulation among the strains (5, 26).
Future studies will determine whether clusters of strains defined by
the sequence of OMP E are associated with subpopulations of M. catarrhalis.
Immunoblot assays of clinical isolates with a battery of eight MAbs
identified a small number of strains which did not react with selected
MAbs. Comparing the amino acid sequences of reactive and nonreactive
strains allows the prediction of epitopes recognized by the antibodies,
since the MAbs are known to recognize specific regions of OMP E. MAbs
1B3 and 9G10d are especially interesting because they recognize an
epitope on the surface of the intact bacterial cell (4).
They may recognize the same epitope since they both bind a fusion
peptide corresponding to amino acids 80 to 180 (17) and
they inhibit the binding of one another to OMP E in a competitive ELISA
(4). Comparison of sequences from amino acids 80 to 180 in
reactive and nonreactive strains reveals differences at three sites,
including amino acids 95, 112 to 117, and 137 and 138 (Table 2). Any or
all three of these sites may be part of the epitope recognized by MAbs
1B3 and 9G10d. Fusion proteins corresponding to sequences in and around
the region of amino acids 107 to 145 did not react with the MAbs,
suggesting either that the epitope is located around amino acid 95 or
that a larger peptide is required to reproduce the conformation of the epitope.
Comparison of sequences and patterns of reactivity with MAbs reveals
that single amino acid differences account for reactivity with selected
MAbs. For example, MAb 12D5 recognizes amino acids 160 to 260 (17). Strain 534 is nonreactive with 12D5 and differs from
reactive strains in a single amino acid in that amino acid range,
indicating that the lysine at position 202 is critical for the epitope
recognized by MAb 12D5. Similarly, MAbs 5B3 and 14E10 recognize amino
acids 240 to 340. Reactive and nonreactive strains differ by a single
amino acid in this region of OMP E. The valine in place of alanine at
position 269, a difference of a single methyl group, accounts for the
lack of reactivity with MAbs 5B3 and 14E10.
The gene which encodes protein P2, the major outer membrane protein of
nontypeable Haemophilus influenzae, undergoes nonsynonymous point mutations under immune selective pressure and undergoes horizontal transfer between strains in the human respiratory tract (7, 8, 24). These are thought to be mechanisms of immune evasion, thereby facilitating persistent colonization of the
respiratory tract. As a preliminary assessment of the stability of OMP
E of M. catarrhalis in the human respiratory tract, the
sequence of ompE was determined in sets of isolates which
colonized the respiratory tracts of adults with COPD continuously for 3 to 9 months. Immunoassays showed that all three patients had serum IgG
to OMP E prior to colonization, and no change in the level was observed
during colonization (Table 3). The genes showed identical nucleotides
at all positions, indicating that the gene did not undergo changes
during persistent colonization. A similar observation has been made
with OMP CD of M. catarrhalis (9).
OMP E has several characteristics which indicate that it may be an
effective vaccine antigen. The protein is present in all strains tested
(2, 3). It is abundantly expressed on the bacterial
surface based on results of immunofluorescence assays and flow
cytometry with MAbs (4). OMP E is immunogenic in animals (4, 17). Some adults with COPD have serum IgG to OMP E,
and the majority have mucosal IgA to OMP E (4). The
present study establishes that OMP E is highly conserved among strains
of M. catarrhalis, an important characteristic for an
effective vaccine antigen.
 |
ACKNOWLEDGMENT |
This work was supported by grant AI28304 from the National
Institute of Allergy and Infectious Diseases and the Department of
Veterans Affairs.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: VA Western New
York Healthcare System, Medical Research 151, 3495 Bailey Ave.,
Buffalo, NY 14215. Phone: (716) 862-7874. Fax: (716) 862-6526. E-mail: murphyt{at}acsu.buffalo.edu.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
American Thoracic Society.
1987.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma.
Am. Rev. Respir. Dis.
136:225-244[Medline].
|
| 2.
|
Bartos, L. C., and T. F. Murphy.
1988.
Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis.
J. Infect. Dis.
158:761-765[Medline].
|
| 3.
|
Bhushan, R.,
R. Craigie, and T. F. Murphy.
1994.
Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis.
J. Bacteriol.
176:6636-6643[Abstract/Free Full Text].
|
| 4.
|
Bhushan, R.,
C. Kirkham,
S. Sethi, and T. F. Murphy.
1997.
Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis.
Infect. Immun.
65:2668-2675[Abstract].
|
| 5.
|
Bootsma, H. J.,
H. G. van der Heide,
S. van de Pas,
L. M. Schouls, and F. R. Mooi.
2000.
Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits.
J. Infect. Dis.
181:1376-1387[CrossRef][Medline].
|
| 6.
|
Brook, I., and A. E. Gober.
1998.
Microbiologic characteristics of persistent otitis media.
Arch. Otolaryngol. Head Neck Surg.
124:1350-1352.
|
| 7.
|
Duim, B.,
L. van Alphen,
P. Eijk,
H. M. Jansen, and J. Dankert.
1994.
Antigenic drift of non-encapsulated Haemophilus influenzae major outer membrane protein P2 in patients with chronic bronchitis is caused by point mutations.
Mol. Microbiol.
11:1181-1189[CrossRef][Medline].
|
| 8.
|
Groeneveld, K.,
L. van Alphen,
C. Voorter,
P. P. Eijk,
H. M. Jansen, and H. C. Zanen.
1989.
Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease.
Infect. Immun.
57:3038-3044[Abstract/Free Full Text].
|
| 9.
|
Hsiao, C. B.,
S. Sethi, and T. F. Murphy.
1995.
Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract.
Microb. Pathog.
19:215-225[CrossRef][Medline].
|
| 10.
|
Kennett, R. H.
1979.
Cell fusion.
Methods Enzymol.
58:345-359[Medline].
|
| 11.
|
Klein, J. O.
1994.
Otitis media.
Clin. Infect. Dis.
19:823-833[Medline].
|
| 12.
|
Klingman, K. L.,
A. Pye,
T. F. Murphy, and S. L. Hill.
1995.
Dynamics of respiratory tract colonization by Moraxella (Branhamella) catarrhalis in bronchiectasis.
Am. J. Respir. Crit. Care Med.
152:1072-1078[Abstract].
|
| 13.
|
Martinez, G.,
K. Ahmed,
C. H. Zheng,
K. Watanabe,
K. Oishi, and T. Nagatake.
1999.
DNA restriction patterns produced by pulsed-field gel electrophoresis in Moraxella catarrhalis isolated from different geographical areas.
Epidemiol. Infect.
122:417[CrossRef][Medline].
|
| 14.
|
Miravitlles, M.,
C. Espinosa,
E. Fernandez-Laso,
J. A. Martos,
J. A. Maldonado,
M. Gallego, and Study Group of Bacterial Infection in COPD.
1999.
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD.
Chest
116:40-46[Abstract/Free Full Text].
|
| 15.
|
Murphy, T. F.
1996.
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.
Microbiol. Rev.
60:267-279[Abstract/Free Full Text].
|
| 16.
|
Murphy, T. F., and L. C. Bartos.
1989.
Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.
Infect. Immun.
57:2938-2941[Abstract/Free Full Text].
|
| 17.
|
Murphy, T. F.,
A. L. Brauer,
N. Yuskiw, and T. J. Hiltke.
2000.
Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants.
Infect. Immun.
68:6250-6256[Abstract/Free Full Text].
|
| 18.
|
Murphy, T. F., and S. Sethi.
1992.
Bacterial infection in chronic obstructive pulmonary disease.
Am. Rev. Respir. Dis.
146:1067-1083[Medline].
|
| 19.
|
Murphy, T. F., and S. Sethi.
1997.
A national strategy for research in chronic obstructive pulmonary disease.
JAMA
277:1596[Abstract/Free Full Text].
|
| 20.
|
Ruuskanen, O., and T. Heikkinen.
1994.
Otitis media: etiology and diagnosis.
Pediatr. Infect. Dis. J.
13:S23-S26.
|
| 21.
|
Sarwar, J.,
A. A. Campagnari,
C. Kirkham, and T. F. Murphy.
1992.
Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.
Infect. Immun.
60:804-809[Abstract/Free Full Text].
|
| 22.
|
Seneff, M. G.,
D. P. Wagner,
R. P. Wagner,
J. E. Zimmerman, and W. A. Knaus.
1995.
Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.
JAMA
274:1852-1857[Abstract/Free Full Text].
|
| 23.
|
Sethi, S., and T. F. Murphy.
2001.
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state of the art review.
Clin. Microbiol. Rev.
14:336-363[Abstract/Free Full Text].
|
| 24.
|
Smith-Vaughan, H. C.,
K. S. Sriprakash,
J. D. Mathews, and D. J. Kemp.
1997.
Nonencapsulated Haemophilus influenzae in aboriginal infants with otitis media: prolonged carriage of P2 porin variants and evidence for horizontal P2 gene transfer.
Infect. Immun.
65:1468-1474[Abstract].
|
| 25.
|
Van Hare, G. F.,
P. A. Shurin,
C. D. Marchant,
N. A. Cartelli,
C. E. Johnson,
D. Fulton,
S. Carlin, and C. H. Kim.
1987.
Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
Rev. Infect. Dis.
9:16-27[Medline].
|
| 26.
|
Verduin, C. M.,
M. Kools-Sijmons,
J. van der Plas,
J. Vlooswijk,
M. Tromp,
H. van Dijk,
J. Banks,
H. Verbrugh, and A. van Belkum.
2000.
Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species.
FEMS Microbiol. Lett.
184:1-8[CrossRef][Medline].
|
| 27.
|
Verghese, A.,
D. Roberson,
J. H. Kalbfleisch, and F. Sarubbi.
1990.
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.
Antimicrob. Agents Chemother.
34:1041-1044[Abstract/Free Full Text].
|
| 28.
|
Vu-Thien, H.,
C. Dulot,
D. Moissenet,
B. Fauroux, and A. Garbarg-Chenon.
1999.
Comparison of randomly amplified polymorphic DNA analysis and pulsed-field gel electrophoresis for typing of Moraxella catarrhalis strains.
J. Clin. Microbiol.
37:450-452[Abstract/Free Full Text].
|
| 29.
|
Walker, E. S.,
R. A. Preston,
J. C. Post,
G. D. Ehrlich,
J. H. Kalbfleisch, and K. L. Klingman.
1998.
Genetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method.
J. Clin. Microbiol.
36:1977-1983[Abstract/Free Full Text].
|
| 30.
|
Wilson, R.
1998.
The role of infection in COPD.
Chest
113:242S-248S[Abstract/Free Full Text].
|
Infection and Immunity, June 2001, p. 3576-3580, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3576-3580.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sardinas, G., Yero, D., Climent, Y., Caballero, E., Cobas, K., Niebla, O.
(2009). Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential. J Med Microbiol
58: 196-208
[Abstract]
[Full Text]
-
Lipski, S. L., Akimana, C., Timpe, J. M., Wooten, R. M., Lafontaine, E. R.
(2007). The Moraxella catarrhalis Autotransporter McaP Is a Conserved Surface Protein That Mediates Adherence to Human Epithelial Cells through Its N-Terminal Passenger Domain. Infect. Immun.
75: 314-324
[Abstract]
[Full Text]
-
Easton, D. M., Smith, A., Gallego, S. G., Foxwell, A. R., Cripps, A. W., Kyd, J. M.
(2005). Characterization of a Novel Porin Protein from Moraxella catarrhalis and Identification of an Immunodominant Surface Loop. J. Bacteriol.
187: 6528-6535
[Abstract]
[Full Text]
-
Jiao, X., Hirano, T., Hou, Y., Gu, X.-X.
(2002). Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate Vaccine. Infect. Immun.
70: 5982-5989
[Abstract]
[Full Text]